The subject of cannabis impairment has been discussed for as long as the plant has been enjoyed, but up until now, the findings have been hazy.  Thankfully, the smoke clouds are clearing, with researchers...

Australia’s medical cannabis market is on a continuous incline, with 6,000+ patients gaining approval for the country’s Special Access Scheme (SAS) Category B pathway as of September. This indicates...